Type(s) of Cancer
Prostate
Prostate
Study Phase
Phase 3
Study Completion Date
May 2008
May 2008
NCT00089674Uploaded 09-26-2016
Available for Download
PDS UID: Prostat_Amgen_2004_154
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer
Files:
PROTOCOL20040138 Protocol Amend 5 REDACTED.pdf
CRFAmgen 20040138 CRF REDACTED.pdf
DATA DICTIONARYAmgen 20040138 DDT.pdf
DATA (COMPARATOR ARM)Amgen 20040138 SAS datasets.zip